Search by Drug Name or NDC
NDC 59627-0222-05 AVONEX Details
AVONEX
AVONEX is a INTRAMUSCULAR KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Biogen Inc.. The primary component is .
MedlinePlus Drug Summary
Interferon beta-1a intramuscular injection is used to treat adults with various forms of multiple sclerosis (MS; a disease in which the nerves do not function properly and people may experience weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control) including: clinically isolated syndrome (CIS; nerve symptom episodes that last at least 24 hours), relapsing-remitting forms (course of disease where symptoms flare up from time to time), or secondary progressive forms (course of disease where relapses occur more often). Interferon beta-1a is in a class of medications called immunomodulators. It works by decreasing inflammation and preventing nerve damage that may cause symptoms of multiple sclerosis.
Related Packages: 59627-0222-05Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Interferon Beta-1a Intramuscular Injection
Interferon beta-1a subcutaneous injection is used to treat adults with various forms of multiple sclerosis (MS; a disease in which the nerves do not function properly and people may experience weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control) including: clinically isolated syndrome (CIS; nerve symptom episodes that last at least 24 hours), relapsing-remitting forms (course of disease where symptoms flare up from time to time), or secondary progressive forms (course of disease where relapses occur more often). Interferon beta-1a is in a class of medications called immunomodulators. It works by decreasing inflammation and preventing nerve damage that may cause symptoms of multiple sclerosis.
Related Packages: 59627-0222-05Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Interferon Beta-1a Subcutaneous Injection
Product Information
| NDC | 59627-0222 |
|---|---|
| Product ID | 59627-222_3ff19956-a793-4256-bff4-7f7443d7238a |
| Associated GPIs | 6240306045F830 |
| GCN Sequence Number | 052882 |
| GCN Sequence Number Description | interferon beta-1a SYRINGEKIT 30MCG/.5ML INTRAMUSC |
| HIC3 | H0E |
| HIC3 Description | AGENTS TO TREAT MULTIPLE SCLEROSIS |
| GCN | 20147 |
| HICL Sequence Number | 011253 |
| HICL Sequence Number Description | INTERFERON BETA-1A |
| Brand/Generic | Brand |
| Proprietary Name | AVONEX |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | interferon beta-1a |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | KIT |
| Route | INTRAMUSCULAR |
| Active Ingredient Strength | n/a |
| Active Ingredient Units | n/a |
| Substance Name | n/a |
| Labeler Name | Biogen Inc. |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA103628 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 59627-0222-05 (59627022205)
| NDC Package Code | 59627-222-05 |
|---|---|
| Billing NDC | 59627022205 |
| Package | 1 KIT in 1 CARTON (59627-222-05) * 1 SYRINGE in 1 TRAY / .5 mL in 1 SYRINGE * 4 POUCH in 1 POUCH / .4 mL in 1 POUCH |
| Marketing Start Date | 2014-08-29 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 8059.23 |
| Pricing Unit | EA |
| Effective Date | 2024-01-01 |
| NDC Description | AVONEX PREFILLED SYR 30 MCG KIT |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |